Advertisement
Canada markets closed
  • S&P/TSX

    22,290.62
    +31.15 (+0.14%)
     
  • S&P 500

    5,187.70
    +6.96 (+0.13%)
     
  • DOW

    38,884.26
    +31.99 (+0.08%)
     
  • CAD/USD

    0.7282
    -0.0004 (-0.06%)
     
  • CRUDE OIL

    78.38
    0.00 (0.00%)
     
  • Bitcoin CAD

    85,805.41
    -1,293.19 (-1.48%)
     
  • CMC Crypto 200

    1,304.36
    -60.76 (-4.45%)
     
  • GOLD FUTURES

    2,322.50
    -1.70 (-0.07%)
     
  • RUSSELL 2000

    2,064.65
    +3.97 (+0.19%)
     
  • 10-Yr Bond

    4.4630
    -0.0260 (-0.58%)
     
  • NASDAQ futures

    18,203.50
    +4.00 (+0.02%)
     
  • VOLATILITY

    13.23
    -0.26 (-1.93%)
     
  • FTSE

    8,313.67
    +100.18 (+1.22%)
     
  • NIKKEI 225

    38,835.10
    +599.03 (+1.57%)
     
  • CAD/EUR

    0.6771
    0.0000 (0.00%)
     

Gilead 2017 Outlook Hamstrung On Hep C, But RBC Bullish On Amgen, Biogen

Gilead 2017 Outlook Hamstrung On Hep C, But RBC Bullish On Amgen, Biogen

Gilead will likely guide to declining 2017 sales, hamstrung on limited Hep C visibility, RBC said Wednesday.